Sign up to save your podcasts
Or
Share Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.
View all episodes
By Healthegy
4.8
5757 ratings
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.
More shows like Medtech Talk
View all
WSJ What’s News
4,322 Listeners
This American Life
90,396 Listeners
Global Medical Device Podcast powered by Greenlight Guru
92 Listeners
Founders
1,942 Listeners
The Daily
111,088 Listeners
The Daily Stoic
4,832 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,249 Listeners
Project Medtech
23 Listeners
The Rest Is History
13,367 Listeners
Huberman Lab
28,636 Listeners
The Ezra Klein Show
15,503 Listeners
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
10 Listeners